<DOC>
	<DOCNO>NCT02786381</DOCNO>
	<brief_summary>This clinical study collect fresh sample perform laboratory test fresh archive sample describe protocol .</brief_summary>
	<brief_title>Idylla IFV-RSV Panel Clinical Testing</brief_title>
	<detailed_description>The Idylla console , instrument , Respiratory ( IFV-RSV ) Panel cartridge constitute Idylla respiratory diagnostic system . The IFV-RSV Panel vitro PCR-based molecular diagnostic assay simultaneous qualitative detection nucleic acid Influenza A ( include H1 , 2009 H1N1 , H275Y mutation 2009 H1N1 , H3 ) , Influenza B , Respiratory Syncytial Virus ( RSV ) ( A B ) nasal swab ( NS ) direct cartridge nasopharyngeal swab ( NP ) viral transport medium ( VTM ) adult , adolescent , child . This clinical study collect data support regulatory submission indication use IFV-RSV panel Idylla diagnostic system . This protocol demonstrate result assay , conjunction clinical information , may use aid diagnosis infection Influenza A , Influenza B , RSV person high low risk respiratory viral infection . During study , participate site collect fresh sample , conduct Reproducibility Study test fresh previously collect frozen sample individual present signs/symptoms influenza like illness ( ILI ) respiratory virus accordance sample collection describe protocol .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Male Female All Ages Subject , legally authorize representative , provide IRB/EC approve write Informed Consent , privacy ( e.g . HIPAA ) authorization require Assent applicable prior studyrelated procedure ( ) perform Patient present ILI and/or Signs/Symptoms RSV Infection define protocol Onset ILI and/or Signs/Symptoms RSV Infection â‰¤ 5 day prior subject screening ( Refer definition detail description ILI Signs/Symptoms RSV infection ) Clinician 's determination illness due viral infection Subject agree allow study specimen use future study Onset Influenza Like Illness ( ILI ) and/or Signs/Symptoms RSV Infection &gt; 5 day prior subject screening ( Refer definition detail description ILI Signs/Symptoms RSV infection ) Subject receive live intranasal attenuate influenza virus last 3 week ( e.g . FluMist , Fluenz ) Subject receive treatment influenza direct antiviral ( e.g . Zanamivir , oseltamivir ( Tamiflu ) , amantadine , rimantadine ) last 5 day The subject previously enrol study Clinician 's determination illness NOT due viral infection ( e.g . allergy ) Subject nasal wash within last 8 hour . This exclusion include extraction nasal secretion nasal suction fluid Subject agree allow study specimen use future research study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>